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Abstract
Most human tumors are characterized by aneuploidy that is believed to be the consequence of chromosomal instability (CIN).
Themechanism(s) leading to aneuploidy and the pathways that allow its tolerance are not completely understood. The Spindle
Assembly Checkpoint (SAC) is a cellular surveillance mechanismworking duringmitosis, and alterations of genes that encode
components of the SAC weakening the mitotic checkpoint, induce aneuploidy by chromosome mis-segregation. We induced
aneuploidy in near-diploid tumor cells by simultaneous depletion of the SAC proteins MAD2 and BUBR1 by RNA
interference in the attempt to gain further insight on the cellular responses to aneuploidy. Individual reduction of MAD2 and
BUBR1 protein levels caused defective mitosis and aneuploidy, while co-depletion of MAD2 and BUBR1 caused cell cycle
arrest and cell death in addition to aneuploidy. The simultaneous reduction of the two SAC proteins induced high percentage
of hyperdiploid cells and p53 stabilization suggesting that hyperdiploidy could activate a p53 controlled pathway. The results
indicate that p53 is required to induce cell cycle arrest and cell death when the mitotic checkpoint is strongly perturbed,
thereby preventing aneuploid cell propagation.
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Introduction
Segregation of genetic material into 2 daughter cells during
mitosis is a highly regulated event and errors during this
phase of the cell cycle can generate cells with aberrant
chromosome numbers (aneuploidy). Precise control of
progression through mitosis is essential to maintain
genomic stability and prevent aneuploidy (Ulrich, in press).
Mutations/alterations in genes encoding mitotic regulators
and defects in genes controlling centrosome numbers and
tumor suppressors have been suggested as possible causes
of aneuploidy (Lentini et al., 2002; Hernando et al., 2004;
Fukasawa, 2005; Iovino et al., 2006; Lentini et al., 2006).
Cells have evolved a surveillance mechanism, the Spindle
Assembly Checkpoint (SAC), which prevents anaphase
onset until all chromosomes are properly attached to
the mitotic spindle ensuring that mitosis is faithfully
accomplished preserving genome stability. The molecular
components of the SAC include Mad1, Mad2, Bubr1,
Bub1, Bub3, and Mps1 proteins. Alteration of MAD2
and BUBR1 expression may because of aneuploidy (Guo
et al., 2012). In particular, human colorectal cancer cells
(HCT116) and murine primary embryonic ﬁbroblasts
(MEFs), in which one MAD2 allele was deleted by
homologous recombination, are highly aneuploid (Michel
et al., 2001; Lentini et al., 2012). Haplo-insufﬁciency of
MAD2 also increases the frequency of aneuploid tumors in a
p53 background (Amato et al., 2009). Intriguingly, aneu-
ploidy and tumorigenesis are also driven by hyperactivation
of MAD2 (Sotillo et al., 2007; Schvartzman et al., 2011).
The Bubr1 protein kinase, encoded by the BUB1B gene, is
a crucial component for several processes controlling
chromosome segregation during mitosis. Genetic mutations
of the Bubr1 kinase occur in the cancer susceptible
disorder, mosaic variegated aneuploidy (MVA) (Matsuura
et al., 2006), which is a rare disorder characterized by
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constitutional mosaic aneuploidies associated in most cases
with premature chromatid separation (PCS), highlighting
the key role of human Bubr1 in chromosome segregation
(Matsuura et al., 2006). Bubr1 also functions in a positive
regulatory loop with the tumor suppressor p53, thus
enhancing apoptosis of polyploid cells (Shin et al., 2003).
It facilitates phosphorylation and stabilization of p53 after
mitotic spindle damage, as well as being a direct p53
transcriptional target (Aylon and Oren, 2011). Inhibition of
Bubr1 in the presence of mitotic poisons accelerates
polyploidy in a p53-null background, reinforcing the idea
that reduction of chromosome segregation ﬁdelity and
acquisition of aneuploid tolerance work synergistically to
promote cancer (Shin et al., 2003). However, the genomic
imbalance caused by aneuploidy reduces ﬁtness of euploid
cells (Torres et al., 2008). Similarly, stable near-diploid
tumor cells that become aneuploid after treatment with
mitotic poisons are removed from the cell population within
few generations (Thompson and Compton, 2008). These
ﬁndings suggest that cancer cells must acquire the ability to
overcome these barriers and that mutations triggering
aneuploidy tolerance should accompany chromosome
missegregation defects. The mechanisms leading to aneu-
ploid tolerance in tumor cells are not yet completely
understood. We found that partial depletion of MAD2
triggered aneuploidy in primary human ﬁbroblasts followed
by p53 stabilization that induced premature cellular
senescence to avoid the deleterious effects of aneuploidy
(Lentini et al., 2012). p53 could be responsible for the
proliferative disadvantage of aneuploidy cells, as suggested
also by p53/ cells in which aneuploidy remains high. Only
a fraction of MAD2 depleted HCT116 cells have whole
chromosome aneuploidy associated with p53 activation
(Li et al., 2010). Furthermore, the presence of aneuploid cells
in vivo and primary MEFs showing aneuploidy has no
proliferative disadvantage, despite having an intact p53
pathway, which suggest that p53 is activated in only some
aneuploid cells (Zasadil et al., 2013).
Partial or complete inhibition of themitotic kinaseAurora B
results in chromosomemisaggregationor failure of cytokinesis.
To limit proliferation of aneuploid cells, a p53-mediated cell
cycle arrest is induced, where p53 might be regulated in two
separate ways, i.e. by being stabilized by inhibition of Aurora B
itself, or by damage to the mitotic spindle apparatus. The
stabilization is insufﬁcient to activate p53 and a second
pathway, the MAP kinase signaling pathway MAP3K4-p38, is
required for transcriptional activation of p53. MAP3K4 might
be activated bymitotic spindle disruption and trigger the signal
top38b. Presumably, p38b targets a transcriptional co-factorof
p53 leading to full activity of p53 and induction of p21.The cell
growth arrest induced by these pathways might prevent
chromosomal instability and therefore suppress tumorigenesis
(Ulrich, in press).
We triggered aneuploidy by weakening the SAC after
post-transcriptional silencing of MAD2 and BUBR1 genes
and investigated whether a p53 controlled pathway is
activated in near-diploid tumor cells (HCT116) with a MIN
(Microsatellite Instability) phenotype to avoid propagation
of highly aneuploidy cells. Individual reduction ofMad2 and
Bubr1 protein levels partially affected cell proliferation and
caused mitotic spindle defects and aneuploidy in near-
diploid HCT116 cells. Conversely, simultaneous Mad2 and
Bubr1 depletion resulted in greater effects, leading to cell
cycle arrest and high mortality.
Materials and methods
Cells and cell culture
Near-diploidHCT116 andHCT116 p53KO cells (a generous
gift of Prof. B. Vogelstein, Ludwig Center for Cancer
Genetics and Therapeutics, Johns Hopkins, Baltimore, MD,
USA) with a MIN phenotype were cultured in D-MEM
supplemented with 10% FBS (GIBCO, Invitrogen),
100 units/mL penicillin and 0.1mg/mL streptomycin in a
humidiﬁed atmosphere of 5% CO2 in air at 37C.
RNA interference
For the RNAi experiments, 2 105 HCT116 cells were
plated in 6-well dishes, incubated at 37C and transfected
24 h after plating with speciﬁc siRNA duplexes. Brieﬂy, the
siRNAs and the transfection reagent (Lipofectamine 2000,
Invitrogen) were diluted separately in Opti-MEM (Invi-
trogen) mixed gently, and then incubated for 5min at RT.
After incubation the siRNAs and Lipofectamine 2000
(Invitrogen) were mixed gently, allowed to sit 30min at
RT to allow complex formation and added to the plates for
72 h. After 6 h at 37C, the transfection medium was
replaced with fresh medium. To silence genes of interest,
post-transcriptionally, cells were transfected with siRNAs
targeting MAD2 (siMAD2: 50-AUACGGACUCAC-
CUUUtt-30) (Michel et al., 2001), siRNAs targeting p53 (si
p53: 50-GCA UGA ACC GGA GGC CCC AUtt-30) (Frame
et al., 2006) and BUBR1 (siBUBR1: 50-GUCUCACA-
GAUUGCUGCCUtt-30) (Choi and Lee, 2008) at 60 nM.
The control siRNA (siGFP: 50-GGCUACGUCCAG-
GAGCGCACCtt-30) targets the Green-Fluorescent-Protein
and was used at 60 nM. All siRNAs (21-nucleotide duplexes)
were synthesized by Euroﬁns-MWG (Germany).
Real time RT-PCR
Primers to be used in Real time RT-PCR experiments were
designed with Primer Express software (Applied Biosys-
tems) choosing amplicons of 70–100 bp. The selected
sequences were tested on public databases (BLAST) to
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conﬁrm the identity of the genes. Total RNA was extracted
from cells by using the RNAeasyMini kit (Qiagen). RNAwas
reverse-transcribed in a ﬁnal volume of 50mL using theHigh
Capacity c-DNA Archive kit (Applied Biosystems) for
10min at 25C and 2 h at 37C. For each sample 2mL of
cDNA, corresponding to 100 ng of reverse transcribed RNA,
were analyzed by Real time RT-PCR (95C for 15 s, 60C for
60 s repeated for 40 cycles), in quadruplicate, using the ABI
PRISM 7300 instrument (Applied Biosystems). Real-time
RT-PCR was done in 20mL comprising 1 Master Mix
SYBR Green (Applied Biosystems) and 0.3mM of forward
and reverse primers for: MAD2 (Fwd:50-GCCGAGTT-
TTTCTCATTTGG-30; Rev:50-CCGATTCTTCCCACTTT-
TCA-30), p53 (Fwd:50-TTCGACATAGTGTGGTGGTGC-
30, Rev:50-AGTCAGAGCCAACCTGAGGC-30), p21waf1
(Fwd: 50-CTGGAGACTCTCAGGGTCGA-30 Rev:50-CGG-
ATTAGGGCTTCCTCTTG-30), BUBR1 (Fwd:50-TACAC-
TGGAAATGACCCTCTGGAT-30, Rev: 50-TATATTATC-
GTTTTTCTCCTTGTAGTGCTT-30), GAPDH (Fwd:50-
CTCATGACCACAGTCCATGCC-30; Rev:50-GCCAATC-
CACAGTCTTCTGGGT-30). Data were analyzed by averag-
ing quadruplicates Ct (cycle threshold). Levels of RNA
expression were determined by using the SDS software
version (Applied Biosystems) according to the 2-DDct
method. Levels of RNA expression of selected genes were
normalized to the internal control GAPDH.
Western blotting
Protein concentrationwasmeasuredusing theBio-RadProtein
Assay (Bio-Rad Laboratories). Proteins (50mg) were separated
by 10% SDS-PAGE containing 0.1% SDS and transferred to
Hybond-C nitrocellulose membranes (Amersham Life Sci-
ence) by electroblotting (Lentini et al., 2014). The membranes
were sequentially incubated with p53-DO1 (mouse, 1:1000),
p21(mouse, 1:1000), Bubr1 (goat, 1:500),Mad2 (goat, 1:200) as
primary antibodies (Santa Cruz,CA), and HRP-conjugated
mouse (1:5000), goat (1:5000), and rabbit IgG (1:5000) (Santa
Cruz,CA) as secondary antibodies. The target protein was
detected with enhanced chemiluminescence Western blotting
detection reagents (PIERCE). Membranes were stained with
Ponceau-Red to conﬁrm equivalent loading of total protein in
all lanes.b-tubulin antibody (mouse; SIGMA-ALDRICH, Italy
1:10.000) was used to conﬁrm proteins loading.
Cell cycle analysis
Asynchronously growing cells were transfected with 60 nM
MAD2 siRNA for 72 h before being pulse labeled with
10mM bromodeoxyuridine (BrdU) for the last 3 h post-
transfection. Cells were ﬁxed and stained with anti-BrdU-
FITC antibody, to detect S-phase cells, and propidium iodide
(PI) to assess the DNA content and analyzed by ﬂow
cytometry. Labeling with BrdU allowed monitoring of cells
actively engaged in DNA synthesis. DNA content was
determined by treating the cells with PBS containing 4mg/mL
of PI and 40mg/mL RNase. BrdU-labeled cells were analyzed
as previously described (Barra et al., 2012; Lentini et al., 2012)
with by FACSCanto (Becton Dickinson). Experiments were
repeated at least twice and >10,000 events were analyzed by
using the FACSDiva software.
Determination of ploidy
Cells were transfected with the speciﬁc siRNA (siGFP,
siMAD2, siMAD2/siBUBR1) for 72 h treated with 0.2mg/mL
colcemid (Demecolcine, SIGMA-ALDRICH, Italy) and 1h,
harvested by trypsinization, swollen in 75mM KCl at 37C,
ﬁxed with 3:1 methanol/acetic acid (v/v), and dropped onto
clean, ice-cold glass microscope slides. The slides were air-
dried and stained with a 3% GIEMSA solution in phosphate-
buffered saline for 10min. Chromosome numbers were
counted using a Zeiss Axioskopmicroscope at a magniﬁcation
of 100  objective.
Trypan blue exclusion test of cell viability
Cells were transfected with the speciﬁc siRNAs (siGFP,
siMAD2, siBUBR1, siMAD2/siBUBR1) for 72 h, harvested by
trypsinization and collected in a tubewith 4mLof phosphate-
buffered saline (PBS). Cell suspension (100mL) were mixed
with 100mL of Trypan Blue (Sigma-Aldrich, Italy) and 10mL
were placed in a Burker chamber for counting.
Immunofluorescence microscopy
To visualize b-tubulin, cells were grown on round glass
coverslips and ﬁxed with ethanol/acetic acid 95:5 for 10min,
permeabilized with 0.01% TritonX (Sigma-Aldrich, Italy) in
PBS for 15min and blocked with 0.1% BSA for 30min at
room temperature. Coverslips were incubated with a mouse
monoclonal antibody against b-tubulin mouse (Sigma-
Aldrich, Italy, diluted 1:200) overnight at 4C, followed by a
goat anti-mouse IgG-FITC secondary antibody (SIGMA-
ALDRICH, Italy, diluted 1:200) for 1 h at 37C. Nuclei were
stained with 1mg/mL 40,6-diamidino-2-phenylindole
(DAPI) and examined on a Zeiss Axioskop microscope
equipped for ﬂuorescence; 200 nuclei for sample were
analyzed and images were captured with a CCD digital
camera (AxioCam, Zeiss) and printed by Adobe PhotoShop.
Results
Co-depletion of MAD2 and BUBR1 by RNAi reduces cell
proliferation
We partially depleted MAD2 and BUBR1 (crucial compo-
nents of the SAC) by RNA interference in HCT116 cells to
investigate if a pathway p53 controlled is activated also in
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near-diploid tumor cells with a MIN phenotype to avoid
propagation of highly aneuploidy cell. Partial reduction of
both mitotic proteins was necessary to avoid deleterious
effects on cell viability, since their complete depletion can
induce death (Michel et al., 2001). Cells were transfected
with speciﬁc synthetic siRNAs targeting MAD2 and BUBR1
transcripts (siMAD2, siBUBR1) and unspeciﬁc siRNA
targeting the green ﬂuorescent protein (siGFP) as a control.
siRNAs targeting MAD2, BUBR1 and GFP transcripts were
transfected individually or combined (siMAD2/siBUBR1,
siMAD2/siGFP). Real-Time RT-PCR analysis showed
decreased levels of MAD2 and BUBR1 transcripts in
transfected HCT116 cells, demonstrating the efﬁcacy of
MAD2 and BUBR1 post-transcriptional silencing by RNAi
(Figure 1A). In comparison to siGFP cells, siMAD2 and
siBUBR1 cells expressed 60% MAD2 and 50% BUBR1
transcripts, respectively (Figure 1A).
Western blot analyses conﬁrmed reduction of Mad2 and
Bubr1 protein levels in siMAD2 and siBUBR1 cells in
comparison to siGFP cells (Figure 1B). At 72 h, post-
transcriptional silencing of MAD2, there was a fourfold
increase of BUBR1 mRNA and protein expression levels
(Figure 1A-B). After BUBR1 posttranscriptional silencing
MAD2 expression was reduced (Figure 1A–B), possibly due
to the slowdown of the cell proliferation.
Early effects (72 h post-transfection) of MAD2 and
BUBR1 partial post-transcriptional silencing resulted in
slowing down of the cell proliferation of HCT-siMAD2 and
HCT-siBUBR1 cells, as indicated by estimation of the
cellular density/dish that was lower than the one of siGFP
cells (Figure 1C, D). Reduction of proliferation was speciﬁc
for cells transfected with siRNAs targeting MAD2 and
BUBR1. In contrast, transfection with unspeciﬁc siRNA
(siGFP) did not affect cell proliferation (Figure 1C, D).
Trypan blue staining showed that double silenced HCT-
siMAD2/siBUBR1 cells had higher mortality (about 80%) in
comparison to HCT-siMAD2 (40%), HCT-siBUBR1 (50%),
and the double silenced HCT-siMAD2/siGFP cells (40%).
Depletion of MAD2 and BUBR1 induces aneuploid cells
and mitotic spindle alterations
To estimate the number of aneuploid cells after
MAD2, BUBR1, and MAD2/BUBR1 post-transcriptional
Figure 1 MAD2 and BUBR1 reduction by RNAi affects cell proliferation and viability. (A) Real-time RT PCR of HCT116 cells after 72 h from
transfection shows reduced levels of both MAD2 and BUBR1 transcripts. (B) Western blot conﬁrmed the reduction of MAD2 and BUBR1 expression also
at protein level. The graph on the right shows increase in protein levels assessed by densitometry. (C) Graph of cell proliferation at 0–24–48, and 72h
post-transfection showing a delay in siMAD2/siBUBR1 transfected cells. (D) Images showing the morphology of transfected cells at 0 and 72h. Double
silencing siMAD2/siBUBR1 transfected cells showed the presence of dead cells (round fragmented cells).
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silencing, cells were treated with colcemid. The great
majority of HCT-siMAD2 and HCT-siBUBR1 aneuploid
cells (Figure 2A-B) were hypodiploid (85 and 82%,
respectively) and the less extent of hyperdiploids (10 and
3%, respectively), whereas co-depleted HCT-siMAD2/
siBUBR1 cells had 18% hyperdiploid cells, 52% hypodip-
loid cells, and 30% euploid cells (Figure 2A-B).
Immunoﬂuorescence microscopy analyses by b-tubulin
staining of HCT-siGFP, HCT-siMAD2, HCT-siBUBR1,
and HCT-siMAD2/siBUBR1 indicated cells with mitotic
spindle alterations as associated with incorrect distribu-
tion of chromosomes (Figure 2C and Figure S1). Various
mitotic spindle defects after MAD2, BUBR1, and MAD2/
BUBR1 post-transcriptional silencing were seen. In
particular, monopolar spindles in 14% siMAD2, 12%
siBUBR1, and 12% of siMAD2/siBUBR1 depleted cells,
disorganized chromosomes in the spindle in 46%
siMAD2, 48% siBUBR1, and 56% of siMAD2/siBUBR1
silenced cells, respectively (Figure S1). In contrast, only
10% of HCT-siGFP cells showed alterations of mitotic
spindle, which suggests that depletion of Mad2 and Bubr1
proteins individually or combined induced alterations of
both chromosomes and the mitotic spindle.
MAD2 and BUBR1 co-depleted cells undergo p53-
dependent cells cycle arrest
The slowing down of proliferation after MAD2, BUBR1 and
MAD2/BUBR1 post-transcriptional silencing (Figure 1C-D)
suggests that part of these cells arrested or proceeded more
slowly in the cell cycle.We therefore assessed by bivariate (PI
and BrdU) FACScan (cytoﬂuorimetric) analyses whether
MAD2, BUBR1 and MAD2/BUBR1 post-transcriptional
silencing was associated to different cell cycle proﬁles in
HCT116 cells. Cells transfected with siRNA duplexes
targeting MAD2, BUBR1, MAD2/BUBR1, and GFP were
analyzed after 72 h from transfection and BrdU was added
for 1 h to assess their ability to enter S-phase (Figure 3A).
FACScan analyses was conducted only on adherent cells and
showed that HCT-siMAD2 and HCT-siBUBR1 accumulat-
ed in G1 (82 and 86%, respectively) and G2/M (10 and 6%,
respectively); only 8% of these cells were in S-phase (BrdU
positive). In contrast, 14% of the HCT-siGFP control cells
entered S-phase. As expected, only a minor fraction of HCT-
siMAD2/siBUBR1 cells were in S-phase (BrdU positive:
0.9%) whereas all the remaining cells arrested in G1/S (87%)
and G2/M (12.1%) (Figure 4A).
Figure 2 MAD2 and BUBR1 HCT116 depleted cells show aneuploidy, spindle alterations, and chromosome misalignment. (A) Histogram
shows percentages of both aneuploid and diploid metaphases in HCT116 cells transfected with siRNA duplexes to repressMAD2 and BUBR1. Results
were from three independent experiments (100–200 cells each) and bars indicate standard errors from the mean. (B) Images of representative GIEMSA-
stained aneuploid metaphases of siMAD2, siBUBR1, and siMAD2/siBUBR1 transfected cells exposed to colcemid. (C) Example of abnormal mitotic cell
with spindle alterations and incorrect chromosome anchorage to the spindle in HCT116 cells after 72 h from transfection with the indicated siRNAs
(siGFP, siMAD2, siBUBR1, siMAD2/siBUBR1). Cells were stained with DAPI to detect chromosomes (blue) and b-tubulin (green).
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Early effects of siMAD2/siBUBR1 post-trascriptional
silencing on cell proliferation in HCT116 cells could be
the result of the activation of a cellular G1/S checkpoint.
Thus expression of the principal genes involved in G1/S
checkpoint were investigated by Real-Time PCR and
Western blot analysis. Increased levels of p21waf1 transcript
and protein in siMAD2/siBUBR1-HCT cells were seen
(Figure 3B–D). The increased level of p21waf1 that may have
been induced by p53 seem to be stabilized, as indicated by its
protein level (Figure 3C, D). To understand whether the p53
and p21waf1 axis was responsible for the observed cell cycle
arrest in siMAD2/siBUBR1-HCT cells, RNAi MAD2 and
BUBR1 genes in combination with the p53 gene were
silenced, and reduction of the MAD2, BUBR1, and p53
transcripts and protein assessed by RT-PCR and western
blotting (Figure 4A, B). Flow cytometry showed that
siMAD2/siBUBR1/siP53-HCT cells could re-enter in the
cell cycle after 72 h from siRNAs transfection (Figure 4C).
siMAD2/siBUBR1/sip53-HCT cells also had a greater
proliferative capacity than siMAD2/siBUBR1-HCT cells
(Figure 4D). However, there was no reduction of p21waf1
mRNA and protein levels after p53 depletion (Figure 4A, B).
Similar results were obtained in cells null for p53; in fact
transfected MAD2/BUBR1 siRNAs in HCT-p53KO cells
proliferated better than HCT-siMAD2/BUBR1 cells after
72 h of transfection (Figure S2A-B). The ﬁndings suggest
that HCT116 cells activate a p53-dependent cell cycle arrest
and death (p21waf1 independent) to prevent aneuploid cells
propagation caused by depletion of MAD2 and BUBR1.
Discussion
Epidemiological and genetic analyses have led to an
estimation of about sixmutations being needed formalignant
transformation on the somatic mutation theory of cancer
(Vogelstein, 1996). Given the mutation rate in humans, it is
extremely rare for a single cell to acquire all the necessary
mutations. Thus, it has been postulated that destabilizing the
genome is necessary for cancer development.
Figure 3 MAD2 and BUBR1 co-depleted cells underwent p53-dependent cells cycle arrest. (A) Cytoﬂuorimetric proﬁles of HCTsiMAD2
HCTsiBUBR1 showing reduction of S-phase cells in respect to HCT-siGFP cells. On the contrary, double-silenced (siMAD2/siBUBR1) cells arrested in G1/S.
DNA was stained with propidium iodide and S-phase by BrdU incorporation. (B) Real-time RT-PCR at 72 h post transfection shows BUBR1 and p21waf1
increased levels in HCT-siMAD2 and HCT-siMAD2/siBUBR1, respectively. (C-D) Western blot analysis conﬁrmed increases of BUBR1 in HCT-siMAD2 and
p53 stabilization associated with an increase in HCT-siMAD2/siBUBR1, respectively. The graph on the right shows increase of protein levels assessed by
densitometry.
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A prominent form of genetic instability in cancer is
chromosomal instability (CIN) that results in gains or losses
of whole chromosomes or translocation of chromosome
segments. Alterations in chromosome number (aneuploidy)
are found in nearly all tumor types of human origin.
Aneuploidy would represent an epiphenomenon of cancer
pathogenesis, a by-product of the hypermutable state
exploited by tumor cells during the process of tumor
progression to accumulate the mutant alleles essential for
malignant proliferation (Zimonjic et al., 2001). However, no
speciﬁc advantages can be associated with a particular gain
or loss of a chromosome most of the time. Previously, we
showed that is not sufﬁcient to induce chromosomal
instability in colon cancer cells with a MIN phenotype by
destabilizing themitotic spindle (for example by centrosome
ampliﬁcation); it has to be associated with alterations in
genes regulating mitosis progression, such as Aurora-
A/STK15 to trigger CIN (Lentini et al., 2007).
Cancer cells can have gross abnormalities in their
chromosome numbers, most as a result of defects in the
quality control of sister chromatid separation (Weaver
et al., 2007). Thus, a complete lack of SAC function does
not cause cell lethality per se; rather, the cells are eliminated by
other protecting mechanisms. Enhanced proteasomal degra-
dation has been suggested as one aneuploidy tolerating
mechanisms (Torres et al., 2010). Also, dysfunction of the
p38-P53 axis has been suggested as promoting proliferationof
aneuploid human tumor cells (Burds et al., 2005). It was also
suggested that heightened energy metabolism in aneuploid
cells may be behind the surge in ROS levels. Increased ROS
causeDNAdamage that activates theATM/P53 pathway, and
this depends on the severity of aneuploidy (Li et al., 2010).
Simultaneous reduction of MAD2 and BUBR1 gene
expression compromises cell viability and are consistent
with previous observations showing that the simultaneous
depletion of SAC genes could be exploited as a possible
strategy to kill cancer cells (Burds et al., 2005). Furthermore,
we suggest the weakening of the SAC checkpoint caused by
MAD2 and BUBR1 reduction increased chromosome
segregation errors, which in turn induced aneuploidy
followed by arrest of cell proliferation and death associated
with p53 stabilization. Following MAD2 transcript reduc-
tion there was a strong increase of the BUBR1 mRNA and
protein expression levels. This is consistent with what
already reported (Shin et al., 2003; Kops et al., 2004) and it
could be correlated with a response to the aneuploidy
(hyperdidploidy) induced by MAD2 depletion (Baker
et al., 2013). Thus, BUBR1 seems to have an important
role against aneuploid cells formation/propagation and its
increase could be necessary to eliminate hyperdiploid cells
from the population. The simultaneous reduction of the
2 SAC proteins induced high percentage of hyperdiploid
Figure 4 P53 silencing induces the re-enter in cell cycle of HCT- siMAD2/siBUBR1 cells (A) Real-time RT PCR shows that in the triple silenced
(siMAD2/siBUBR1/siP53) cells p21waf1 expression was similar of that in double (siMAD2/siBUBR1) silenced cells, and that p53 mRNA reduction was
50%. (B) Western blot analysis showing that p53 was very low after triple silencing (siMAD2/siBUBR1/siP53), whereas p21waf1 was always more
expressed that in control cells. (C-D) Cytoﬂuorimetry showing that triple-silenced (siMAD2/siBUBR1/siP53) cells re-enter cell cycle (presence of S-phase
cells) and less dead cells (in suspension) in culture.
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cells and p53 stabilization, suggesting that hyperdiploidy
could activate a p53 controlled pathway accordingly to
published reports (Thompson and Compton DA:, 2010;
Stuabach, in press). On the contrary, aneuploid cells
generated by single silencing of MAD2 or BUBR1 did not
show high levels of hyperdiploidy and did not activate the
p53-controlled checkpoint. This conclusion is supported by
p53 post-transcriptional silencing by siRNA in MAD2 and
BUBR1
co-depleted cells allowing cells to re-enter the cell cycle. This
was also seen in cells null for p53 (HCT-p53KO), when
MAD2 and BUBR1 were simultaneously silenced. After p53
depletion by RNAi, we unexpectedly did not ﬁnd a decrease
of p21waf1 protein levels, which suggests that p21waf1 is only
partially involved in the arrest of the cell cycle observed in
HCT116-MAD2/BUBR1 cells and that its increase in
aneuploidy cells is not only under the p53 control.
In conclusion, our results indicate thatMAD2 and BUBR1
reduction causes mitotic spindle dis-organization and
incorrect distribution of chromosomes along the spindle
in the absence of mitotic poisons, and, importantly, that a
p53-controlled pathway is required to induce cell cycle arrest
or cell death to avoid aneuploid cells proliferation.
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